mohamed bouchoucha
Quick facts
Marketed products
- metronidazole based quadriple therapy · Gastroenterology / Infectious Disease
Metronidazole-based quadruple therapy combines metronidazole with three other agents (typically a proton pump inhibitor, bismuth compound, and tetracycline or clarithromycin) to eradicate Helicobacter pylori through multiple antimicrobial and acid-suppressive mechanisms. - placebo based quadriple therapy
A placebo-based quadruple therapy that relies on the placebo effect across four treatment components to produce therapeutic benefit.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about mohamed bouchoucha
What are mohamed bouchoucha's marketed drugs?
Top marketed products include metronidazole based quadriple therapy, placebo based quadriple therapy.
Related
- metronidazole based quadriple therapy · Gastroenterology / Infectious Disease
- placebo based quadriple therapy
- Sector hub: All tracked pharma companies